Contact
QR code for the current URL

Story Box-ID: 1286013

AB Cube Germany GmbH Rosental 5 80331 München, Germany https://marvin.now
Contact Mr Jens Wissing

Marvin, asthenis and SafetyEasy® join forces under AB Cube Group

Integrated portfolio of real-world and clinical trial data strengthens oncology research and safety workflows.

(PresseBox) (München, )
AB Cube Group is bringing together Marvinasthenis, and SafetyEasy® into one integrated portfolio of solutions for real-world and clinical trial data — supporting oncology research, clinical studies, and pharmacovigilance workflows across Europe. 

As part of this transformation, EvidentIQ Germany GmbH is now operating under the name AB Cube Germany GmbH. In addition, asthenis Medical GmbH has been integrated into AB Cube Germany GmbH. 

This combination strengthens AB Cube’s footprint in Germany and Europe and expands its offering for life-science organizations — covering clinical data management, structured oncology documentation, tumor boards, and regulatory safety processes. 

Integrated solutions for oncology research and safety 

The transformation unites three complementary strengths: 
  • Marvin — clinical data management for clinical trials and registries, with a strong focus on oncology workflows 
  • asthenis — tumor documentation, oncology registries, and multidisciplinary tumor boards 
  • SafetyEasy® — pharmacovigilance, vigilance, and regulatory safety workflows 
The integration links Marvin’s oncology trial expertise with asthenis’ strengths in tumor documentation and tumor boards, that connects clinical trial data with structured real-world oncology care data. 

SafetyEasy® complements the portfolio by adding safety and vigilance workflows, enabling a more integrated approach across clinical trials, real-world data, and regulatory compliance. 

Together, AB Cube Group now supports customers with an integrated set of tools for: 
  • Clinical data management for studies and registries 
  • Oncology documentation and structured real-world data capture 
  • Tumor conferences and tumor boards 
  • Pharmacovigilance and vigilance reporting 
  • Regulatory compliance workflows 
For further information on AB Cube Group, please contact AB Cube Germany GmbH. 

About AB Cube SAS AB Cube SAS is a pioneer in cloud-based vigilance and safety software for the life sciences industry. Since 2006, AB Cube has developed innovative SaaS solutions, including the SafetyEasy® Suite, that help organizations worldwide manage complex safety, pharmacovigilance, medical device vigilance, cosmetic vigilance, and regulatory reporting workflows with flexibility, automation, and compliance at their core.

AB Cube Germany GmbH

AB Cube Germany GmbH, (formerly XClinical), is a leading European provider of eClinical technologies and the developer of the platforms Marvin EDC and asthenis.

Marvin offers an integrated suite of clinical modules, including EDC, IWRS/RTSM, Medical Coding, ePRO, and advanced reporting tools, designed to support complex and oncology-focused clinical trials.

asthenis is an oncology-focused documentation, registry, and tumour board solution used primarily by hospitals and academic institutions. It captures real-world cancer patient data from routine clinical practice and supports registries and outcomes research.

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2026, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.